Menu
Yaohai Bio-Pharma offers expert regulatory affairs support for biologics, from regulatory strategy consulting to IND/BLA submissions, We provide CMC regulatory consulting, dossier preparation, regulatory liaison, and inspection support to ensure lifecycle management for global projects.
Contact our team to discuss regulatory strategy, IND/BLA submissions, and CMC regulatory support for your biologic projects.
We provide end-to-end regulatory affairs support for biologics, covering CMC consulting, regulatory submissions, global strategy and inspection readiness.
Our regulatory affairs team delivers strategic guidance, regulatory submission expertise, and cross-functional coordination to support biologics projects throughout CMC ddevelopments.
Backed by 15+ years of experience in drug registration, regulatory submission strategy, and global regulatory coordination.
Supported 300+ projects across biologics development, regulatory documentation and submission pathways.
Access to up-to-date regulatory intelligence, agency guidance updates, and region-specific submission requirements.
Comprehensive support from early planning through IND and BLA submissions.
Robust project planning , cross-functional coordination and timeline control throughout each regulatory program.
Customized regulatory solutions aligned with product development stage, submission strategy, and target market requirements.
Explore our tailored CRDMO services and innovative solutions designed to support your biologics development from concept to commercialization.
provide one-stop CMC solutions for biologics, with a strong focus on recombinant proteins/peptides, plasmid DNA, nano-bodies, novel recombinant vaccines, and therapeutic plasmids. Our services are driven by customer needs—efficient, flexible, and reliable.
We provide comprehensive CRDMO services—from process development, IND-CMC studies, and GMP manufacturing to NDA submission and MAH-based commercial production—enabling the full journey from DNA to commercialization.
Access the latest updates on company news, events, and technical articles.
Ut fames nibh euismod fermentum justo velit ultricies nunc duis placerat taciti. Torquent quam nisi integer fermentum accumsan litora. Efficitur potenti hac imperdiet laoreet vel vivamus placerat platea augue taciti. Dictum ultricies efficitur metus aliquet consectetuer pulvinar vivamus eget.
Ut fames nibh euismod fermentum justo velit ultricies nunc duis placerat taciti. Torquent quam nisi integer fermentum accumsan litora. Efficitur potenti hac imperdiet laoreet vel vivamus placerat platea augue taciti. Dictum ultricies efficitur metus aliquet consectetuer pulvinar vivamus eget.
Ut fames nibh euismod fermentum justo velit ultricies nunc duis placerat taciti. Torquent quam nisi integer fermentum accumsan litora. Efficitur potenti hac imperdiet laoreet vel vivamus placerat platea augue taciti. Dictum ultricies efficitur metus aliquet consectetuer pulvinar vivamus eget.
Ut fames nibh euismod fermentum justo velit ultricies nunc duis placerat taciti. Torquent quam nisi integer fermentum accumsan litora. Efficitur potenti hac imperdiet laoreet vel vivamus placerat platea augue taciti. Dictum ultricies efficitur metus aliquet consectetuer pulvinar vivamus eget.
Ut fames nibh euismod fermentum justo velit ultricies nunc duis placerat taciti. Torquent quam nisi integer fermentum accumsan litora. Efficitur potenti hac imperdiet laoreet vel vivamus placerat platea augue taciti. Dictum ultricies efficitur metus aliquet consectetuer pulvinar vivamus eget.
We provide regulatory affairs support for biologics projects across key submission stages, helping clients prepare, coordinate and advance IND/BLA submissions with greater clarity and efficiency.
Support for IND submission planning, documentation preparation, and regulatory coordination to enable efficient initiation of clinical development.
CMC regulatory consulting and documentation support for quality-related submissions across development stages.
Strategic and operational support for BLA dossier preparation, compilation, and submission readiness to facilitate marketing authorization.
Practical support for regulatory activities across global authorities, including agency communication, submission maintenance, and regulatory documentation management.
We provide end-to-end regulatory solutions designed to navigate the complex global biologics landscape. Our expertise covers the full product lifecycle: from initial CMC regulatory strategy and gap analysis, through IND/BLA/MAA submission preparation, to post-approval maintenance and ongoing regulatory compliance support across all major and emerging global markets.
Absolutely. We provide comprehensive support for both clinical and commercial phases. For INDs, we focus on submission documentation and strategy to ensure a smooth clinical start. For BLAs, MAAs, and other regional marketing authorizations, we offer high-level strategic and operational support, including dossier writing, submission planning, and managing agency interactions to facilitate successful commercial entry worldwide.
We provide comprehensive regulatory support for global development programs. Our team has extensive experience in navigating the regulatory requirements of diverse jurisdictions, including but not limited to the U.S. (FDA), European Union (EMA), China (NMPA), Australia (TGA), and other international markets. We tailor our regulatory strategy to ensure your product meets the specific compliance and submission pathways of your target markets globally.
CMC is the cornerstone of our expertise. Beyond general document preparation, we provide deep technical consulting to ensure that your manufacturing processes, analytical methods, and facility data meet stringent regulatory standards. We align our CMC strategy with global expectations, ensuring your development data is “submission-ready” at every stage of the project.
Yes. We provide proactive support for agency interactions, including pre-submission meetings and response-to-query cycles. Furthermore, our team specializes in inspection readiness, providing on-site support and rigorous preparation to ensure that your manufacturing facilities and quality systems consistently meet the high standards of global regulatory bodies.
We go beyond mere documentation. Our experts provide in-depth technical evaluations, submission reviews, and product-specific risk assessments. We act as your regulatory partner, tracking the status of your submission, coordinating cross-functional responses to regulatory queries, and ensuring your program remains strictly on schedule.
